Pay in 4 interest-free payments of $5.30 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
The peptide was discovered in 2015, and human clinical data remain scarce
Clinical research involving approximately 900 participants across six human trials has validated AOD-9604 s selective fat-targeting effects
The timing depends on deficiency severity, symptoms, and blood test results
Nicotinamide N-methyltransferase as a potential therapeutic target in neurodegenerative diseases
The optional Precision Peptide Genetic Test analyzes 17 Longevity insights including FOXO3 the most-studied longevity gene, linked to centenarian populations and cellular repair capacity with crossover into Energy Metabolism, Tissue Repair, and Cognition pathways
Research-grade peptides vary in purity
US$ 21.95
US$ 21.46
US$ 28.10
US$ 28.62
:max_bytes(150000):strip_icc()/Health-GettyImages-1675158771-70640c9fdf1b41078975cfc3fd538a6b.jpg)
:max_bytes(150000):strip_icc()/GettyImages-1299286851-18ab6e02931940ad963dda93851b6dc7.jpg)
